What happened
JW Lifescience filed provisional (unaudited) separate results for Q1 2026: revenue of US$39.8M (−4.48% year on year), operating profit of US$5.99M (−14.01% year on year) and net income of US$4.18M (−12.39% year on year).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$39.8M |
|---|---|
| Revenue vs a year earlier | −4.48% |
| Operating profit | US$5.99M |
| Net income | US$4.18M |
| Period | Q1 2026 (separate) |
| Filed | 2026-05-13, Operating results (preliminary) (fair disclosure) |
| Source | DART rcept 20260513800898 → open original filing |
Source: DART. Information only, not investment advice.